59865-15-5 Usage
Uses
Used in Pharmaceutical Research:
Dihydrocyclosporin A is used as a control substance for [application reason] to determine the role of immunosuppression in the pharmacology of cyclosporin A, particularly in the treatment of parasitic infections.
Used in Immunosuppressive Drug Development:
As an analog of cyclosporin A, Dihydrocyclosporin A is used as a reference compound for [application type] in the development of new immunosuppressive drugs, aiding in understanding the differences in their mechanisms of action and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 59865-15-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,8,6 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 59865-15:
(7*5)+(6*9)+(5*8)+(4*6)+(3*5)+(2*1)+(1*5)=175
175 % 10 = 5
So 59865-15-5 is a valid CAS Registry Number.
InChI:InChI=1/C62H113N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h34-47,49-52,75H,25-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/t40-,41+,42-,43+,44+,45+,46-,47+,49+,50+,51?,52-/m1/s1
59865-15-5Relevant articles and documents
Synthesis and neurotrophic activity of nonimmunosuppressant cyclosporin A derivatives
Wei, Ling,Steiner, Joseph P.,Hamilton, Gregory S.,Wu, Yong-Qian
, p. 4549 - 4551 (2004)
In order to exploit cyclophilin as a potential target for neurological drug design, we demonstrate in this presentation that several nonimmunosuppressant analogues of cyclosporin A, modified at the various positions in the 'effector' domain, are equipotent nerve growth agents compared to cyclosporin A. Our results suggest that neurotrophic activity of cyclosporin A and its derivatives resides in the binding domain, and binding to cyclophilin and/or inhibiting rotamase activity may be a necessity for neurotrophic effects of cyclophilin ligands.